Related Experiment Videos
Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene
L L Wessner1, M Fan, D O Schaeffer
1Department of Pathology, University of Tennessee College of Veterinary Medicine, Knoxville 37901, USA.
Abstract:
A pharmacogenetic mouse model was utilized to determine the role of Cyp1a1 expression on the formation of Ki-ras mutations in lung tumors following transplacental exposure to polycyclic aromatic hydrocarbons (PAHs). A backcross between Ah responsive male B6D2F1 mice and nonresponsive female DBA mice resulted in a litter in which both responsive and nonresponsive fetuses resided in the same nonresponsive maternal environment. Pregnant mothers received a single i.p. injection of either 10 or 30 mg/kg of 3-methylcholanthrene (MC) or olive oil vehicle on day 17 of gestation. At the higher dose of MC, the responsive offspring of both sexes had significantly (P < 0.05) higher incidences of lung tumors than their nonresponsive littermates. The male responsive mice also exhibited a significantly increased liver tumor incidence over the nonresponsive mice at the P < 0.05 level. Administration of 10 mg/kg of MC caused a very low incidence of lung tumors and did not result in the appearance of macroscopically visible liver tumors. Exons 1 and 2 of the Ki-ras gene were amplified from paraffin-embedded tissue samples. The PCR products were screened by allele-specific oligonucleotide hybridization (ASO). Thirteen of 16 lung tumors (81%) screened exhibited point mutations in the 12th or 13th codon, including seven tumors that contained GGT-->GTT (GLY12-->VAL12) transversions, four which exhibited GGT-->TGT (GLY12-->CYS12) transversions, and two which contained GGC-->CGC (GLY13-->ARG13) transversions. None of the tumors had mutations at codon 61. The results obtained by ASO were confirmed by cloning and sequence analysis of the PCR products from four of these tumors. Within the subset of 16 tumors examined in this study, the same types of mutations in the Ki-ras gene were generally present in both responsive and nonresponsive mice, although G-->C transversions were found in two tumors from a single responsive female mouse. Interestingly, while both males and females exhibited the GGT-->GTT mutations at codon 12, the GGT-->TGT transversion was only found in male mice. These results are consistent with a key role for Cyp1a1 in modulating individual susceptibility to cancer formation through the formation of reactive intermediates that bind to DNA and result in activating mutations in key regulatory molecules.
Insights
Cytochrome P450 family 1 subfamily A member 1 (Cyp1a1) expression influences cancer risk by affecting polycyclic aromatic hydrocarbon (PAH) metabolism. This study shows Cyp1a1 activity is key in PAH-induced mutations and tumor formation in mice.
Area of Science:
- Pharmacogenetics
- Chemical carcinogenesis
- Molecular toxicology
Background:
- Polycyclic aromatic hydrocarbons (PAHs) are environmental carcinogens requiring metabolic activation.
- Cytochrome P450 family 1 subfamily A member 1 (Cyp1a1) plays a crucial role in metabolizing PAHs into reactive intermediates.
- Individual susceptibility to PAH-induced cancers varies, potentially due to differences in Cyp1a1 expression.
Purpose of the Study:
- To investigate the role of Cyp1a1 expression in the formation of Ki-ras mutations in lung tumors.
- To determine the impact of transplacental exposure to PAHs on tumor development in a pharmacogenetic mouse model.
Main Methods:
- Utilized a pharmacogenetic mouse model with varying Cyp1a1 responsiveness (B6D2F1 x DBA backcross).
- Administered 3-methylcholanthrene (MC), a PAH, via intraperitoneal injection to pregnant mice on day 17 of gestation.
- Analyzed Ki-ras gene mutations (exons 1 and 2) in lung tumors using allele-specific oligonucleotide hybridization (ASO) and sequencing.
Main Results:
- Responsive offspring exposed to higher MC doses showed significantly higher incidences of lung tumors compared to nonresponsive littermates.
- Male responsive mice also exhibited a significantly increased incidence of liver tumors.
- Eighty-one percent of screened lung tumors (13/16) had point mutations in Ki-ras codons 12 or 13, primarily GGT→GTT and GGT→TGT transversions.
Conclusions:
- Cyp1a1 plays a critical role in modulating susceptibility to PAH-induced cancer formation.
- Metabolic activation by Cyp1a1 generates reactive intermediates that can lead to activating mutations in oncogenes like Ki-ras.
- Genetic variations in Cyp1a1 influence individual risk for chemically induced cancers.